Lorson CL[au] - Search Results

Year	Number of Results
1998	2
1999	3
2000	3
2001	3
2002	5
2003	1
2004	2
2005	2
2006	2
2007	3
2008	11
2009	8
2010	7
2011	10
2012	9
2013	4
2014	3
2015	3
2016	4
2017	9
2018	3
2019	6
2020	4
2021	10
2022	7

1

Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses.

Kannan SR, Spratt AN, Cohen AR, Naqvi SH, Chand HS, Quinn TP, Lorson CL, Byrareddy SN, Singh K. Kannan SR, et al. Among authors: lorson cl. J Autoimmun. 2021 Nov;124:102715. doi: 10.1016/j.jaut.2021.102715. Epub 2021 Aug 11. J Autoimmun. 2021. PMID: 34399188 Free PMC article.

2

Retraction notice: the SMN structure reveals its crucial role in snRNP assembly.

Seng CO, Magee C, Young PJ, Lorson CL, Allen JP. Seng CO, et al. Among authors: lorson cl. Hum Mol Genet. 2016 Dec 15;25(24):5516. doi: 10.1093/hmg/ddw355. Hum Mol Genet. 2016. PMID: 28031290 No abstract available.

3

A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy.

Lorson CL, Hahnen E, Androphy EJ, Wirth B. Lorson CL, et al. Proc Natl Acad Sci U S A. 1999 May 25;96(11):6307-11. doi: 10.1073/pnas.96.11.6307. Proc Natl Acad Sci U S A. 1999. PMID: 10339583 Free PMC article.

4

Factors Associated with Emerging and Re-emerging of SARS-CoV-2 Variants.

Spratt AN, Kannan SR, Woods LT, Weisman GA, Quinn TP, Lorson CL, Sönnerborg A, Byrareddy SN, Singh K. Spratt AN, et al. Among authors: lorson cl. bioRxiv. 2021 Mar 24:2021.03.24.436850. doi: 10.1101/2021.03.24.436850. Preprint. bioRxiv. 2021. PMID: 33791700 Free PMC article.

5

Infectivity of SARS-CoV-2: there Is Something More than D614G?

Kannan SR, Spratt AN, Quinn TP, Heng X, Lorson CL, Sönnerborg A, Byrareddy SN, Singh K. Kannan SR, et al. Among authors: lorson cl. J Neuroimmune Pharmacol. 2020 Dec;15(4):574-577. doi: 10.1007/s11481-020-09954-3. Epub 2020 Sep 15. J Neuroimmune Pharmacol. 2020. PMID: 32930936 Free PMC article. No abstract available.

6

Discovery and in-vitro evaluation of potent SARS-CoV-2 entry inhibitors.

Acharya A, Pandey K, Thurman M, Klug E, Trivedi J, Lorson CL, Singh K, Byrareddy SN. Acharya A, et al. Among authors: lorson cl. bioRxiv. 2021 Apr 2:2021.04.02.438204. doi: 10.1101/2021.04.02.438204. Preprint. bioRxiv. 2021. PMID: 33821265 Free PMC article. Updated.

7

Evolution, correlation, structural impact and dynamics of emerging SARS-CoV-2 variants.

Spratt AN, Kannan SR, Woods LT, Weisman GA, Quinn TP, Lorson CL, Sönnerborg A, Byrareddy SN, Singh K. Spratt AN, et al. Among authors: lorson cl. Comput Struct Biotechnol J. 2021;19:3799-3809. doi: 10.1016/j.csbj.2021.06.037. Epub 2021 Jun 24. Comput Struct Biotechnol J. 2021. PMID: 34188776 Free PMC article.

8

RNA-targeting approaches for neuromuscular diseases.

Le Roy F, Charton K, Lorson CL, Richard I. Le Roy F, et al. Among authors: lorson cl. Trends Mol Med. 2009 Dec;15(12):580-91. doi: 10.1016/j.molmed.2009.10.005. Epub 2009 Nov 10. Trends Mol Med. 2009. PMID: 19906562 Review.

9

Coronavirus helicases: attractive and unique targets of antiviral drug-development and therapeutic patents.

Spratt AN, Gallazzi F, Quinn TP, Lorson CL, Sönnerborg A, Singh K. Spratt AN, et al. Among authors: lorson cl. Expert Opin Ther Pat. 2021 Apr;31(4):339-350. doi: 10.1080/13543776.2021.1884224. Epub 2021 Apr 21. Expert Opin Ther Pat. 2021. PMID: 33593200 Free PMC article. Review.

10

Discovery and Evaluation of Entry Inhibitors for SARS-CoV-2 and Its Emerging Variants.

Acharya A, Pandey K, Thurman M, Klug E, Trivedi J, Sharma K, Lorson CL, Singh K, Byrareddy SN. Acharya A, et al. Among authors: lorson cl. J Virol. 2021 Nov 23;95(24):e0143721. doi: 10.1128/JVI.01437-21. Epub 2021 Sep 22. J Virol. 2021. PMID: 34550770 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results